Walking program shows promise for easing fatigue in metastatic breast cancer

NCT ID NCT04354233

Completed Symptom relief Sponsor: Centre Leon Berard Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a 6-month physical activity program using a fitness tracker could help women with metastatic breast cancer feel better and less tired. 124 women with hormone receptor-positive, HER2-negative metastatic breast cancer who were starting chemotherapy took part. Half received activity recommendations plus a tracker and weekly quizzes, while the other half got recommendations only. The goal was to see if the program could delay worsening of quality of life and fatigue.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast carcinoma breast neoplasm Fatigue Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC BREAST CANCER

Contacts and locations

Locations

AP-HP

Paris, France
CGFL

Dijon, France
CH Cholet

Cholet, France
CH Cotentin

Cherbourg, France
CH Fleyriat

Bourg-en-Bresse, France
CH Morlaix

Morlaix, France
CHU Amiens

Amiens, France
CHU Avignon

Avignon, France
Centre Eugène Marquis

Rennes, France
Centre Léon Bérard (CLB)

Lyon, 69008, France
Groupement Hospitalier Mutualiste

Grenoble, France
Hospices Civils de Lyon

Lyon, France
Institut Curie

Paris, France
Institut Godinot

Reims, France
Institut Gustave Roussy

Villejuif, France
Institut de Cancérologie Lucien Neuwirth (ICLN)

Saint-Etienne, France
Institut de Cancérologie de l'Ouest (ICO)

Angers, France
Institut de Cancérologie de l'Ouest (ICO)

Saint-Herblain, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.